[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@synapse_surfer Sub Cellular
Sub Cellular posts on X about $atyr, $mrus, $mltx, approved the most. They currently have XX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +484%
- X Month XXXXX +943%
Mentions: XX #
Followers: XX #
- X Week XX +157%
- X Month XX +350%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence finance XXXX%
Social topic influence $atyr 23.08%, $mrus 7.69%, $mltx 7.69%, approved 7.69%, $abvx 7.69%, prob XXXX%
Top accounts mentioned or mentioned by @sanctuary_bio @joserestonva @biotech2k1 @amaymd @plainyogurt21 @sanctuarybio @uchiwawa @seedy19tron @biotechfuru @avidresearch @ic50cent @thumbsupbio @zapunyo @a_a_free @aaron51687924 @a_may_md @ic50_cent @bowtiedbiotech @dub_k1 @btcbabey
Top assets mentioned Merus N.V. Common Shares (MRUS) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)
Top Social Posts #
Top posts by engagements in the last XX hours
"@JoseRestonVA @Sanctuary_Bio Just digging into $MRUS. Could you provide me your high level thesis Upcoming readouts Launch expectations Cheers"
@synapse_surfer on X 2025-07-25 18:16:29 UTC XX followers, XXX engagements
"@Biotech2k1 $MLTX has a great drug I'd be curious what you think of $ATYR with a Ph3 readout in pulmonary sarcoidosis. Novel MOA patients self-report feeling better and signs of steroid tapering. Management has disclosed blinded data shows segregation of two populations. Small 1b/2a" @synapse_surfer on X 2025-07-24 23:26:18 UTC XX followers, XXX engagements
"@A_May_MD @uchi_wawa @seedy19tron How important is maintenance data to a buyout Is there any chance residual hesitation about this asset will force them to commercialize themselves" @synapse_surfer on X 2025-07-23 05:24:27 UTC XX followers, XXX engagements
"Predicted breakdown of clinical remission for $ABVX given XX% treatment failure @A_May_MD seems in line with approved biologics (Entyvio Skyrizi Omvoh)" @synapse_surfer on X 2025-07-24 20:37:35 UTC XX followers, XXX engagements
"@BiotechFuru Prob worth noting that tapering to 5mg is sig different than 0mg (Ph3 endpoint)" @synapse_surfer on X 2025-07-26 15:31:18 UTC XX followers, XXX engagements
"@avidresearch Well see if $ATYR follows suit" @synapse_surfer on X 2025-07-25 23:02:46 UTC XX followers, XXX engagements
"Treatment effect on patient reported questionnaires in lung disease notoriously disappointing. The stat sig signal across X measurements for $atyr ph1b/2a therefore stands out" @synapse_surfer on X 2025-07-24 15:44:28 UTC XX followers, XXX engagements
"@IC50_cent What do you make of dose response in PRO data 5mg showing stat sig across all X measures" @synapse_surfer on X 2025-07-26 15:40:45 UTC XX followers, XX engagements
"Its only watershed if we can crack chronic pain indications. Keeping a close eye on Latigo Bio" @synapse_surfer on X 2025-07-25 23:57:03 UTC XX followers, XX engagements